HumanCo Acquisition Corp. Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing January 28, 2021
HumanCo Acquisition Corp. (NASDAQ: HMCOU) announced that starting January 28, 2021, holders of its IPO units can separate and trade Class A common stock and redeemable warrants. The units were originally offered in an underwritten offering totaling 28,750,000 units. Citigroup Global Markets acted as the sole book-running manager, with a registration statement effective December 8, 2020. The announcement stipulates that no fractional warrants will be issued upon separation. The company aims to pursue acquisitions mainly in the Health and Wellness sectors.
- None.
- None.
AUSTIN, Texas, Jan. 27, 2021 /PRNewswire/ -- HumanCo Acquisition Corp. (NASDAQ: HMCOU) (the "Company") announced that, commencing January 28, 2021, holders of the units sold in the Company's initial public offering of 28,750,000 units may elect to separately trade the shares of Class A common stock and redeemable warrants included in the units. Those units not separated will continue to trade on The Nasdaq Capital Market ("Nasdaq") under the symbol "HMCOU," and the shares of Class A common stock and redeemable warrants that are separated will trade on Nasdaq under the symbols "HMCO" and "HMCOW," respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into shares of Class A common stock and redeemable warrants.
The units were initially offered by the Company in an underwritten offering. Citigroup Global Markets Inc. acted as sole book-running manager. A registration statement relating to the units and the underlying securities became effective on December 8, 2020.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The offering was made only by means of a prospectus, copies of which may be obtained for free from the Securities and Exchange Commission (the "SEC") website at www.sec.gov or by contacting Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: 1-800-831-9146.
About HumanCo Acquisition Corp.
HumanCo Acquisition Corp. is a blank check company incorporated as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to focus on the industries that complement the management team's background, and to capitalize on their demonstrated ability to identify and acquire businesses focusing on Health and Wellness and related industries in the United States. For more information about HumanCo Acquisition Corp., please visit www.humancospac.com.
Forward-Looking Statements
This press release may include "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including with respect to the anticipated separate trading of the Company's Class A common stock and redeemable warrants and the pursuit of an initial business combination. All statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus relating to the Company's initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact
Amy Zipper
Chief Operating Officer
amy@humanco.com
View original content:SOURCE HumanCo Acquisition Corp.
FAQ
When can HMCOU shareholders start trading their shares separately?
What are the trading symbols for HumanCo Acquisition Corp's separated shares?
How many units were offered in HumanCo Acquisition Corp's initial public offering?
Who managed the underwritten offering for HumanCo Acquisition Corp?
What is the focus of HumanCo Acquisition Corp's future acquisitions?
